Search research articles
Contact Us
Filters
Showing results (61-70 of 166) with videos related to
Page
of 17
Sort By:
Journal of Clinical Pharmacology
|
July 1, 1988
Acute effects of the new angiotensin-converting enzyme inhibitor cilazapril: a pilot study
R A Mulinari, I Gouni, I Gavras, et al.
Clinical Science and Molecular Medicine. Supplement
|
December 1, 1976
Determination of renin-dependency and sodium-dependency in the three renin sub-groups of essential hypertension
H Gavras, A Ribeiro, H R Brunner, et al.
Journal of Clinical Pharmacology
|
August 1, 1984
Pilot study of the effects of the angiotensin-converting enzyme inhibitor CI-906 on patients with essential hypertension
I Gavras, D Vlahakos, J C Melby, et al.
Journal of Clinical Pharmacology
|
November 1, 1981
Safety and efficacy of chronic therapy with captopril in hypertensive patients: an update
B Waeber, I Gavras, H R Brunner, et al.
Peptides
|
November 1, 1990
A new highly potent antagonist of bradykinin
B Lammek, Y X Wang, I Gavras, et al.
Science (New York, N.Y.)
|
August 22, 1980
Sodium-induced elevation of blood pressure in the anephric state
P Hatzinikolaou, H Gavras, H R Brunner, et al.
The American Journal of Physiology
|
June 1, 1981
Role of vasopressin, catecholamines, and plasma volume in hypertonic saline-induced hypertension
P Hatzinikolaou, H Gavras, H R Brunner, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 19, 2000
Role of alpha(2)-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice
K P Makaritsis, C Johns, I Gavras, et al.
The Journal of Laboratory and Clinical Medicine
|
March 1, 1992
Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats
Y X Wang, I Gavras, T Wierzba, et al.
The Journal of Laboratory and Clinical Medicine
|
April 1, 1991
Effects of chronic administration of a vasopressin antagonist with combined antivasopressor and antiantidiuretic activities in rats with left ventricular dysfunction
Y X Wang, R Franco, I Gavras, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 166) with videos related to
Sort By:
Page
of 17
Journal of Clinical Pharmacology
|
July 1, 1988
Acute effects of the new angiotensin-converting enzyme inhibitor cilazapril: a pilot study
R A Mulinari, I Gouni, I Gavras, et al.
Clinical Science and Molecular Medicine. Supplement
|
December 1, 1976
Determination of renin-dependency and sodium-dependency in the three renin sub-groups of essential hypertension
H Gavras, A Ribeiro, H R Brunner, et al.
Journal of Clinical Pharmacology
|
August 1, 1984
Pilot study of the effects of the angiotensin-converting enzyme inhibitor CI-906 on patients with essential hypertension
I Gavras, D Vlahakos, J C Melby, et al.
Journal of Clinical Pharmacology
|
November 1, 1981
Safety and efficacy of chronic therapy with captopril in hypertensive patients: an update
B Waeber, I Gavras, H R Brunner, et al.
Peptides
|
November 1, 1990
A new highly potent antagonist of bradykinin
B Lammek, Y X Wang, I Gavras, et al.
Science (New York, N.Y.)
|
August 22, 1980
Sodium-induced elevation of blood pressure in the anephric state
P Hatzinikolaou, H Gavras, H R Brunner, et al.
The American Journal of Physiology
|
June 1, 1981
Role of vasopressin, catecholamines, and plasma volume in hypertonic saline-induced hypertension
P Hatzinikolaou, H Gavras, H R Brunner, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 19, 2000
Role of alpha(2)-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice
K P Makaritsis, C Johns, I Gavras, et al.
The Journal of Laboratory and Clinical Medicine
|
March 1, 1992
Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats
Y X Wang, I Gavras, T Wierzba, et al.
The Journal of Laboratory and Clinical Medicine
|
April 1, 1991
Effects of chronic administration of a vasopressin antagonist with combined antivasopressor and antiantidiuretic activities in rats with left ventricular dysfunction
Y X Wang, R Franco, I Gavras, et al.
Page
of 17